Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Metabolomics for the Identification of Endometrial Biomarkers for Recurrent Pregnancy Loss and Reccurent Implantation Failure Following in Vitro Fertilization.

NCT03690830 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT03690830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03690830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Metabolomics for the Identification of Endometrial Biomarkers for Recurrent Pregnancy Loss and Reccurent Implantation Failure Following in Vitro Fertilization.
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2019
Completion date
January 1, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent implantation failure, recurrent pregnancy loss